NASDAQ: INSMInsmed Inc Stock Ownership - Who owns Insmed?
Insider buying vs selling
Have Insmed Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Melvin Md Sharoky | Director | 2025-12-05 | 20,000 | $205.01 | $4.10MSell |
| William Lewis | Chair and CEO | 2025-12-04 | 1,040 | $207.42 | $215.72kSell |
| William Lewis | Chair and CEO | 2025-12-04 | 2,921 | $206.49 | $603.16kSell |
| William Lewis | Chair and CEO | 2025-12-04 | 4,440 | $17.16 | $76.19kBuy |
| William Lewis | Chair and CEO | 2025-12-04 | 4,516 | $204.62 | $924.06kSell |
| William Lewis | Chair and CEO | 2025-12-04 | 2,222 | $205.66 | $456.98kSell |
| William Lewis | Chair and CEO | 2025-12-04 | 6,259 | $30.46 | $190.65kBuy |
| Martina Md Flammer | Chief Medical Officer | 2025-12-01 | 5,886 | $207.03 | $1.22MSell |
| Martina Md Flammer | Chief Medical Officer | 2025-12-01 | 1,559 | $207.73 | $323.85kSell |
| Martina Md Flammer | Chief Medical Officer | 2025-12-01 | 8,895 | $25.83 | $229.76kBuy |
INSM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when INSM insiders and whales buy or sell their stock.
INSM Shareholders
What type of owners hold Insmed Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jpmorgan Chase Co | 10.81% | 23,047,676 | $4.54B | Institution |
| Richard S. Kollender | 10.28% | 21,924,540 | $4.32B | Insider |
| Darwin Global Management Ltd | 9.59% | 20,457,445 | $4.03B | Institution |
| Vanguard Group Inc | 9.35% | 19,935,820 | $3.93B | Institution |
| Blackrock Inc | 5.80% | 12,364,904 | $2.44B | Institution |
| Fmr LLC | 4.30% | 9,180,963 | $1.81B | Institution |
| Capital International Investors | 3.54% | 7,553,853 | $1.49B | Institution |
| Price T Rowe Associates Inc | 3.25% | 6,931,466 | $1.37B | Institution |
| Baker Bros Advisors LP | 3.14% | 6,703,484 | $1.32B | Institution |
| D E Shaw Co Inc | 2.65% | 5,657,464 | $1.11B | Institution |
INSM vs Biotech Stocks
Insmed Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.